Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lilly's E-Venture Fund: Getting In At The Bottom

This article was originally published in Start Up

Executive Summary

With investors still generally staying out of e-health, a couple of Big Pharma companies think it's time to get in. First, Merck & Co. Inc. announced last November that former Merck-Medco chairman, Per Lofberg would head a $100 million fund dedicated to Internet Health care. And now, Eli Lilly & Co. has just launched the $50 million e.Lilly Venture Fund. Lilly's fund, which will focus on companies with technologies that the company can use, rather than return on investment, will make investments of up to $3 million in 12 to 15 companies over the next year or so.

Related Content

Corporate Venture Capital's Complex Agenda


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts